Enanta Pharmaceuticals In...

NASDAQ: ENTA · Real-Time Price · USD
8.00
0.26 (3.36%)
At close: Aug 15, 2025, 3:59 PM
8.00
0.00%
After-hours: Aug 15, 2025, 04:01 PM EDT

Enanta Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
PE Ratio
-1.89 -1.75 -8.78 -14.51
PEG Ratio
0.13 -0.22 -0.17 -0.12
PS Ratio
3.24 2.96 12.40 11.80
PB Ratio
1.70 1.08 3.33 2.87
P/FCF Ratio
-2.27 -2.09 -12.3 -16.2
P/OCF Ratio
-2.78 -2.27 -12.61 -16.37
OCF/S Ratio
-1.16 -1.3 -0.98 -0.72
Debt / Equity Ratio
1.75 0.12 0.08 0.01
Quick Ratio
5.21 6.73 10.45 8.82
Current Ratio
5.21 6.73 10.45 8.82
Asset Turnover
0.18 0.17 0.23 0.22
Interest Coverage
-11.12 -26.65 n/a n/a
Return on Equity
-0.9 -0.62 -0.38 -0.2
Return on Assets
-0.31 -0.29 -0.32 -0.18
Return on Invested Capital
-0.34 -0.32 -0.35 -0.2
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 1.00 1.00
Net Profit Margin
-1.72 -1.69 -1.41 -0.81
Pretax Profit Margin
-1.74 -1.65 -1.42 -1.11
Operating Profit Margin
-1.8 -1.73 -1.44 -1.13
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-1.55 -1.56 -1.38 -1.07